{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:08:37Z","timestamp":1793272117975,"version":"4.5.0"},"reference-count":57,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"DOI":"10.61622\/rbgo\/2025rbgo54","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:13:11Z","timestamp":1752682391000},"source":"Crossref","is-referenced-by-count":2,"title":["Pathophysiological mechanisms in severe preeclampsia: role of upregulated proteins in blood pressure, extracellular matrix and immunity"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-9550","authenticated-orcid":false,"given":"Caroline Cristina","family":"Pinto-Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-8488","authenticated-orcid":false,"given":"Julyane Natsumi Saito","family":"Kaihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-9610","authenticated-orcid":false,"given":"Bruno C\u00e9sar","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5010-4914","authenticated-orcid":false,"given":"Ricardo de Carvalho","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-1825","authenticated-orcid":false,"given":"Lucilene Delazari dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6168-7470","authenticated-orcid":false,"given":"Val\u00e9ria Cristina","family":"Sandrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"issue":"1","key":"key20250716161306_B1","first-page":"1","article-title":"ACOG Practice Bulletin No. 202 Summary: gestational hypertension and preeclampsia","volume":"133","year":"2019","unstructured":"ACOG Practice Bulletin No. 202 Summary: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. doi: 10.1097\/AOG.0000000000003019","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key20250716161306_B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","article-title":"Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Deanfield","year":"2005","unstructured":"Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7-17. doi: 10.1097\/00004872-200501000-00004","journal-title":"J Hypertens"},{"issue":"4","key":"key20250716161306_B3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/antiox12040795","article-title":"Preeclampsia affects lipid metabolism and HDL function in mothers and their offspring","volume":"12","author":"Stadler","year":"2023","unstructured":"Stadler JT, Scharnagl H, Wadsack C, Marsche G. Preeclampsia affects lipid metabolism and HDL function in mothers and their offspring. Antioxidants (Basel). 2023;12(4):795. doi: 10.3390\/antiox12040795","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"key20250716161306_B4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/acb.2010.035","article-title":"Management of severe preeclampsia","volume":"65","author":"Brichant","year":"2010","unstructured":"Brichant G, Dewandre PY, Foidart JM, Brichant JF. Management of severe preeclampsia. Acta Clin Belg. 2010;65(3):163-9. doi: 10.1179\/acb.2010.035","journal-title":"Acta Clin Belg"},{"issue":"1","key":"key20250716161306_B5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.20854","article-title":"Validation of Delphi procedure consensus criteria for defining fetal growth restriction","volume":"56","author":"Molina","year":"2020","unstructured":"Molina LC, Odibo L, Zientara S, Obi\u010dan SG, Rodriguez A, Stout M, et al. Validation of Delphi procedure consensus criteria for defining fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(1):61-6. doi: 10.1002\/uog.20854","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"key20250716161306_B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","unstructured":"Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333-9. doi: 10.1002\/uog.15884","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"key20250716161306_B7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/uog.19196","article-title":"Essential variables for reporting research studies on fetal growth restriction: a Delphi consensus","volume":"53","author":"Khalil","year":"2019","unstructured":"Khalil A, Gordijn SJ, Beune IM, Wynia K, Ganzevoort W, Figueras F, et al. Essential variables for reporting research studies on fetal growth restriction: a Delphi consensus. Ultrasound Obstet Gynecol. 2019;53(5):609-14. doi: 10.1002\/uog.19196","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key20250716161306_B8","doi-asserted-by":"crossref","first-page":"S819","DOI":"10.1016\/j.ajog.2020.08.108","article-title":"Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance","volume":"226","author":"Fishel Bartal","year":"2022","unstructured":"Fishel Bartal M, Lindheimer MD, Sibai BM. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am J Obstet Gynecol. 2022;226(2 Suppl):S819-34. doi: 10.1016\/j.ajog.2020.08.108","journal-title":"Am J Obstet Gynecol"},{"key":"key20250716161306_B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2021.03.002","article-title":"Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women","volume":"92","author":"Bertozzi-Matheus","year":"2021","unstructured":"Bertozzi-Matheus M, Bueno-Pereira TO, Viana-Mattioli S, Carlstr\u00f6m M, Cavalli RC, Sandrim VC. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women. Clin Biochem. 2021;92:25-33. doi: 10.1016\/j.clinbiochem.2021.03.002","journal-title":"Clin Biochem"},{"issue":"4","key":"key20250716161306_B10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/diseases11040155","article-title":"Plasma eNOS concentration in healthy pregnancy and in hypertensive disorders of pregnancy: evidence of reduced concentrations in pre-eclampsia from two independent studies","volume":"11","author":"Kaihara","year":"2023","unstructured":"Kaihara JN, Minami CK, Pera\u00e7oli MT, Rom\u00e3o-Veiga M, Ribeiro-Vasques VR, Pera\u00e7oli JC, et al. Plasma eNOS concentration in healthy pregnancy and in hypertensive disorders of pregnancy: evidence of reduced concentrations in pre-eclampsia from two independent studies. Diseases (Basel). 2023;11(4):155. doi: 10.3390\/diseases11040155","journal-title":"Diseases (Basel)"},{"issue":"1","key":"key20250716161306_B11","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1038\/s41598-017-09272-4","article-title":"Myeloperoxidase is not a good biomarker for preeclampsia prediction","volume":"7","author":"Rocha-Penha","year":"2017","unstructured":"Rocha-Penha L, Bettiol H, Barbieri MA, Cardoso VC, Cavalli RC, Sandrim VC. Myeloperoxidase is not a good biomarker for preeclampsia prediction. Sci Rep. 2017;7(1):10257. doi: 10.1038\/s41598-017-09272-4","journal-title":"Sci Rep"},{"issue":"6","key":"key20250716161306_B12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217273","article-title":"The prediction of early preeclampsia: results from a longitudinal proteomics study","volume":"14","author":"Tarca","year":"2019","unstructured":"Tarca AL, Romero R, Benshalom-Tirosh N, Than NG, Gudicha DW, Done B, et al. The prediction of early preeclampsia: results from a longitudinal proteomics study. PLoS One. 2019;14(6):e0217273. doi: 10.1371\/journal.pone.0217273","journal-title":"PLoS One"},{"issue":"1","key":"key20250716161306_B13","doi-asserted-by":"crossref","first-page":"19099","DOI":"10.1038\/s41598-022-20658-x","article-title":"Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia","volume":"12","author":"Chen","year":"2022","unstructured":"Chen H, Aneman I, Nikolic V, Karadzov Orlic N, Mikovic Z, Stefanovic M, et al. Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia. Sci Rep. 2022;12(1):19099. doi: 10.1038\/s41598-022-20658-x","journal-title":"Sci Rep"},{"issue":"7","key":"key20250716161306_B14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181468","article-title":"The prediction of late-onset preeclampsia: results from a longitudinal proteomics study","volume":"12","author":"Erez","year":"2017","unstructured":"Erez O, Romero R, Maymon E, Chaemsaithong P, Done B, Pacora P, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLoS One. 2017;12(7):e0181468. doi: 10.1371\/journal.pone.0181468","journal-title":"PLoS One"},{"issue":"6","key":"key20250716161306_B15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1248\/bpb.b20-01043","article-title":"Identification and validation of combination plasma biomarker of afamin, fibronectin and sex hormone-binding globulin to predict pre-eclampsia","volume":"44","author":"Uchida","year":"2021","unstructured":"Uchida Y, Higuchi T, Shirota M, Kagami S, Saigusa D, Koshiba S, et al. Identification and validation of combination plasma biomarker of afamin, fibronectin and sex hormone-binding globulin to predict pre-eclampsia. Biol Pharm Bull. 2021;44(6):804-15. doi: 10.1248\/bpb.b20-01043","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"key20250716161306_B16","doi-asserted-by":"crossref","first-page":"16189","DOI":"10.1038\/s41598-017-15882-9","article-title":"Integrated proteomic and metabolomic prediction of term preeclampsia","volume":"7","author":"Bahado-Singh","year":"2017","unstructured":"Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, et al. Integrated proteomic and metabolomic prediction of term preeclampsia. Sci Rep. 2017;7(1):16189. doi: 10.1038\/s41598-017-15882-9","journal-title":"Sci Rep"},{"issue":"16","key":"key20250716161306_B17","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.3390\/ijms25168738","article-title":"Different proteomic profiles regarding antihypertensive therapy in preeclampsia pregnant","volume":"25","author":"Pinto-Souza","year":"2024","unstructured":"Pinto-Souza CC, Kaihara JN, Nunes PR, Mastella MH, Rossini BC, Cavecci-Mendon\u00e7a B, et al. Different proteomic profiles regarding antihypertensive therapy in preeclampsia pregnant. Int J Mol Sci. 2024;25(16):8738. doi: 10.3390\/ijms25168738","journal-title":"Int J Mol Sci"},{"issue":"5","key":"key20250716161306_B18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1095\/biolreprod.110.090688","article-title":"Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas","volume":"84","author":"Zhang","year":"2011","unstructured":"Zhang HH, Wang YP, Chen DB. Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas. Biol Reprod. 2011;84(5):966-75. doi: 10.1095\/biolreprod.110.090688","journal-title":"Biol Reprod"},{"issue":"1","key":"key20250716161306_B19","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41598-021-82733-z","article-title":"Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics","volume":"11","author":"Youssef","year":"2021","unstructured":"Youssef L, Miranda J, Blasco M, Paules C, Crovetto F, Palomo M, et al. Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics. Sci Rep. 2021;11(1):3048. doi: 10.1038\/s41598-021-82733-z","journal-title":"Sci Rep"},{"issue":"7","key":"key20250716161306_B20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3858\/emm.2011.43.7.047","article-title":"Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis","volume":"43","author":"Park","year":"2011","unstructured":"Park J, Cha DH, Lee SJ, Kim YN, Kim YH, Kim KP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med. 2011;43(7):427-35. doi: 10.3858\/emm.2011.43.7.047","journal-title":"Exp Mol Med"},{"issue":"8","key":"key20250716161306_B21","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1021\/pr100198m","article-title":"Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia","volume":"9","author":"Rasanen","year":"2010","unstructured":"Rasanen J, Girsen A, Lu X, Lapidus JA, Standley M, Reddy A, et al. Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. J Proteome Res. 2010;9(8):4274-81. doi: 10.1021\/pr100198m","journal-title":"J Proteome Res"},{"issue":"9","key":"key20250716161306_B22","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900029","article-title":"Targeted and untargeted proteomics approaches in biomarker development","volume":"20","author":"Sobsey","year":"2020","unstructured":"Sobsey CA, Ibrahim S, Richard VR, Gaspar V, Mitsa G, Lacasse V, et al. Targeted and untargeted proteomics approaches in biomarker development. Proteomics. 2020;20(9):e1900029. doi: 10.1002\/pmic.201900029","journal-title":"Proteomics"},{"issue":"1","key":"key20250716161306_B23","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi: 10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"key20250716161306_B24","first-page":"516","volume-title":"Biostatistical analysis","author":"Zar","year":"1999","unstructured":"Zar JH. Biostatistical analysis. 4th ed. Upper Saddle River: Prentice Hall; 1999. More on dichotomous variables; p. 516-70.","edition":"4th ed."},{"issue":"7","key":"key20250716161306_B25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9(7):811-8. doi: 10.1002\/sim.4780090710","journal-title":"Stat Med"},{"issue":"1","key":"key20250716161306_B26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37-46. doi: 10.1177\/001316446002000104","journal-title":"Educ Psychol Meas"},{"issue":"D1","key":"key20250716161306_B27","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-13. doi: 10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"key20250716161306_B28","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","unstructured":"Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34(Database issue):D535-9. doi: 10.1093\/nar\/gkj109","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"key20250716161306_B29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.4083","article-title":"A scored human protein-protein interaction network to catalyze genomic interpretation","volume":"14","author":"Li","year":"2017","unstructured":"Li T, Wernersson R, Hansen RB, Horn H, Mercer J, Slodkowicz G, et al. A scored human protein-protein interaction network to catalyze genomic interpretation. Nat Methods. 2017;14(1):61-4. doi: 10.1038\/nmeth.4083","journal-title":"Nat Methods"},{"key":"key20250716161306_B30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2. doi: 10.1186\/1471-2105-4-2","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"key20250716161306_B31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12014-021-09313-1","article-title":"Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004-2020 period: a systematic review","volume":"18","author":"Navajas","year":"2021","unstructured":"Navajas R, Corrales F, Paradela A. Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004-2020 period: a systematic review. Clin Proteomics. 2021;18(1):6. doi: 10.1186\/s12014-021-09313-1","journal-title":"Clin Proteomics"},{"issue":"1","key":"key20250716161306_B32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1515\/jpm-2022-0433","article-title":"Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for prevention","volume":"51","author":"Than","year":"2022","unstructured":"Than NG, Romero R, Gy\u00f6rffy D, Posta M, Bhatti G, Done B, et al. Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for prevention. J Perinat Med. 2022;51(1):51-68. doi: 10.1515\/jpm-2022-0433","journal-title":"J Perinat Med"},{"key":"key20250716161306_B33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fphys.2015.00011","article-title":"A1M\/\u03b11-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation","volume":"6","author":"Cederlund","year":"2015","unstructured":"Cederlund M, Deronic A, Pallon J, S\u00f8rensen OE, \u00c5kerstr\u00f6m B. A1M\/\u03b11-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation. Front Physiol. 2015;6:11. doi: 10.3389\/fphys.2015.00011","journal-title":"Front Physiol"},{"issue":"4","key":"key20250716161306_B34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.placenta.2011.01.017","article-title":"Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by \u03b11-microglobulin","volume":"32","author":"May","year":"2011","unstructured":"May K, Rosenl\u00f6f L, Olsson MG, Centlow M, M\u00f6rgelin M, Larsson I, et al. Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by \u03b11-microglobulin. Placenta. 2011;32(4):323-32. doi: 10.1016\/j.placenta.2011.01.017","journal-title":"Placenta"},{"issue":"1-2","key":"key20250716161306_B35","doi-asserted-by":"crossref","first-page":"1600082","DOI":"10.1002\/prca.201600082","article-title":"Elevated levels of protein AMBP in cerebrospinal fluid of women with preeclampsia compared to normotensive pregnant women","volume":"11","author":"van den Berg","year":"2017","unstructured":"van den Berg CB, Duvekot JJ, G\u00fczel C, Hansson SR, de Leeuw TG, Steegers EA, et al. Elevated levels of protein AMBP in cerebrospinal fluid of women with preeclampsia compared to normotensive pregnant women. Proteomics Clin Appl. 2017;11(1-2):1600082. doi: 10.1002\/prca.201600082","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"key20250716161306_B36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","unstructured":"Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, MacHin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-20. doi: 10.1111\/j.1365-2141.2009.08022.x","journal-title":"Br J Haematol"},{"key":"key20250716161306_B37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejogrb.2020.08.005","article-title":"The association of the prothrombin G20210A single-nucleotide polymorphism and the risk of preeclampsia: systematic review and meta-analysis","volume":"253","author":"Ahmed","year":"2020","unstructured":"Ahmed NA, Hamdan HZ, Kamis AH, Adam I. The association of the prothrombin G20210A single-nucleotide polymorphism and the risk of preeclampsia: systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;253:162-9. doi: 10.1016\/j.ejogrb.2020.08.005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20250716161306_B38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejogrb.2015.09.021","article-title":"Associations between phenotypes of preeclampsia and thrombophilia","volume":"194","author":"Berks","year":"2015","unstructured":"Berks D, Duvekot JJ, Basalan H, De Maat MP, Steegers EA, Visser W. Associations between phenotypes of preeclampsia and thrombophilia. Eur J Obstet Gynecol Reprod Biol. 2015;194:199-205. doi: 10.1016\/j.ejogrb.2015.09.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"key20250716161306_B39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pmic.200300565","article-title":"Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia","volume":"4","author":"Watanabe","year":"2004","unstructured":"Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa-Kobayashi K, Yoshikawa H, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics. 2004;4(2):537-43. doi: 10.1002\/pmic.200300565","journal-title":"Proteomics"},{"issue":"6","key":"key20250716161306_B40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1933719111430999","article-title":"Plasma clusterin increased prior to small for gestational age (SGA) associated with preeclampsia and decreased prior to SGA in normotensive pregnancies","volume":"19","author":"Blumenstein","year":"2012","unstructured":"Blumenstein M, McCowan LM, Wu S, Cooper GJ, North RA; SCOPE consortium. Plasma clusterin increased prior to small for gestational age (SGA) associated with preeclampsia and decreased prior to SGA in normotensive pregnancies. Reprod Sci. 2012;19(6):650-7. doi: 10.1177\/1933719111430999","journal-title":"Reprod Sci"},{"issue":"7","key":"key20250716161306_B41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/1357-2725(95)00027-M","article-title":"Clusterin: physiologic and pathophysiologic considerations","volume":"27","author":"Rosenberg","year":"1995","unstructured":"Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol. 1995;27(7):633-45. doi: 10.1016\/1357-2725(95)00027-m","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"key20250716161306_B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(97)00298-3","article-title":"Role of vitronectin and its receptors in haemostasis and vascular remodeling","volume":"89","author":"Preissner","year":"1998","unstructured":"Preissner KT, Seiffert D. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res. 1998;89(1):1-21. doi: 10.1016\/s0049-3848(97)00298-3","journal-title":"Thromb Res"},{"issue":"3","key":"key20250716161306_B43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14789450.2017.1291345","article-title":"Plasma biomarkers for the identification of women at risk for early-onset preeclampsia","volume":"14","author":"Kolialexi","year":"2017","unstructured":"Kolialexi A, Tsangaris GT, Sifakis S, Gourgiotis D, Katsafadou A, Lykoudi A, et al. Plasma biomarkers for the identification of women at risk for early-onset preeclampsia. Expert Rev Proteomics. 2017;14(3):269-76. doi: 10.1080\/14789450.2017.1291345","journal-title":"Expert Rev Proteomics"},{"issue":"1","key":"key20250716161306_B44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00404-014-3601-1","article-title":"Evaluation of Lp-PLA2 mass, vitronectin and PAI-1 activity levels in patients with preeclampsia","volume":"292","author":"Balc\u0131 Ekmek\u00e7i","year":"2015","unstructured":"Balc\u0131 Ekmek\u00e7i \u00d6, Ekmek\u00e7i H, G\u00fcng\u00f6r Z, T\u00fcten A, Toprak MS, Korkmaz M, et al. Evaluation of Lp-PLA2 mass, vitronectin and PAI-1 activity levels in patients with preeclampsia. Arch Gynecol Obstet. 2015;292(1):53-8. doi: 10.1007\/s00404-014-3601-1","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"key20250716161306_B45","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1933719109342756","article-title":"Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia","volume":"16","author":"Blumenstein","year":"2009","unstructured":"Blumenstein M, Prakash R, Cooper GJ, North RA; SCOPE Consortium. Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia. Reprod Sci. 2009;16(12):1144-52. doi: 10.1177\/1933719109342756","journal-title":"Reprod Sci"},{"key":"key20250716161306_B46","doi-asserted-by":"crossref","first-page":"103663","DOI":"10.1016\/j.jri.2022.103663","article-title":"The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients","volume":"153","author":"L\u00f6b","year":"2022","unstructured":"L\u00f6b S, Vattai A, Kuhn C, Mittelberger J, Herbert SL, W\u00f6ckel A, et al. The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients. J Reprod Immunol. 2022;153:103663. doi: 10.1016\/j.jri.2022.103663","journal-title":"J Reprod Immunol"},{"key":"key20250716161306_B47","doi-asserted-by":"crossref","first-page":"103267","DOI":"10.1016\/j.jri.2020.103267","article-title":"Pregnancy Zone Protein (PZP) is significantly upregulated in the decidua of recurrent and spontaneous miscarriage and negatively correlated to Glycodelin A (GdA)","volume":"143","author":"L\u00f6b","year":"2021","unstructured":"L\u00f6b S, Vattai A, Kuhn C, Schmoeckel E, Mahner S, W\u00f6ckel A, et al. Pregnancy Zone Protein (PZP) is significantly upregulated in the decidua of recurrent and spontaneous miscarriage and negatively correlated to Glycodelin A (GdA). J Reprod Immunol. 2021;143:103267. doi: 10.1016\/j.jri.2020.103267","journal-title":"J Reprod Immunol"},{"key":"key20250716161306_B48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2016.08.018","article-title":"PZP and PAI-2: structurally-diverse, functionally similar pregnancy proteins?","volume":"79","author":"Wyatt","year":"2016","unstructured":"Wyatt AR, Cater JH, Ranson M. PZP and PAI-2: structurally-diverse, functionally similar pregnancy proteins? Int J Biochem Cell Biol. 2016;79:113-7. doi: 10.1016\/j.biocel.2016.08.018","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"key20250716161306_B49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.004755","article-title":"Proteome- and transcriptome-wide genetic analysis identifies biological pathways and candidate drug targets for preeclampsia","volume":"17","author":"Ardissino","year":"2024","unstructured":"Ardissino M, Truong B, Slob EA, Schuermans A, Yoshiji S, Morley AP, et al. Proteome- and transcriptome-wide genetic analysis identifies biological pathways and candidate drug targets for preeclampsia. Circ Genom Precis Med. 2024;17(5):e004755. doi: 10.1161\/CIRCGEN.124.004755","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"key20250716161306_B50","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2005-09-3755","article-title":"Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II","volume":"107","author":"Giri","year":"2006","unstructured":"Giri TK, Tollefsen DM. Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. Blood. 2006;107(7):2753-8. doi: 10.1182\/blood-2005-09-3755","journal-title":"Blood"},{"issue":"9","key":"key20250716161306_B51","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/hmg\/dds006","article-title":"Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases","volume":"21","author":"Chelbi","year":"2012","unstructured":"Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet. 2012;21(9):1968-78. doi: 10.1093\/hmg\/dds006","journal-title":"Hum Mol Genet"},{"issue":"5","key":"key20250716161306_B52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jprot.2009.12.014","article-title":"Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology","volume":"73","author":"Auer","year":"2010","unstructured":"Auer J, Camoin L, Guillonneau F, Rigourd V, Chelbi ST, Leduc M, et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics. 2010;73(5):1004-17. doi: 10.1016\/j.jprot.2009.12.014","journal-title":"J Proteomics"},{"issue":"11","key":"key20250716161306_B53","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/pmic.200800625","article-title":"A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease","volume":"9","author":"Blumenstein","year":"2009","unstructured":"Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, et al. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics. 2009;9(11):2929-45. doi: 10.1002\/pmic.200800625","journal-title":"Proteomics"},{"key":"key20250716161306_B54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2019.08.034","article-title":"Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction","volume":"300","author":"Zhao","year":"2020","unstructured":"Zhao L, Zheng M, Guo Z, Li K, Liu Y, Chen M, et al. Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction. Int J Cardiol. 2020;300:34-8. doi: 10.1016\/j.ijcard.2019.08.034","journal-title":"Int J Cardiol"},{"issue":"8488","key":"key20250716161306_B55","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(86)91269-9","article-title":"Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy","volume":"327","author":"Murphy","year":"1986","unstructured":"Murphy JF, Newcombe RG, O\u2019Riordan J, Coles EC, Pearson JF. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet. 1986;327(8488):992-5. doi: 10.1016\/s0140-6736(86)91269-9","journal-title":"Lancet"},{"key":"key20250716161306_B56","doi-asserted-by":"crossref","first-page":"1285S","DOI":"10.1093\/ajcn\/71.5.1285s","article-title":"Maternal hemoglobin concentration and birth weight","volume":"71","author":"Steer","year":"2000","unstructured":"Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr. 2000;71(5 Suppl):1285S-7S. doi: 10.1093\/ajcn\/71.5.1285s","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"key20250716161306_B57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135080","article-title":"An origin of cooperative oxygen binding of human adult hemoglobin: different roles of the \u03b1 and \u03b2 subunits in the \u03b12\u03b22 tetramer","volume":"10","author":"Nagatomo","year":"2015","unstructured":"Nagatomo S, Nagai Y, Aki Y, Sakurai H, Imai K, Mizusawa N, et al. An origin of cooperative oxygen binding of human adult hemoglobin: different roles of the \u03b1 and \u03b2 subunits in the \u03b12\u03b22 tetramer. PLoS One. 2015;10(8):e0135080. doi: 10.1371\/journal.pone.0135080","journal-title":"PLoS One"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:13:19Z","timestamp":1752682399000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/pathophysiological-mechanisms-in-severe-preeclampsia-role-of-upregulated-proteins-in-blood-pressure-extracellular-matrix-and-immunity\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"alternative-id":["10.61622\/rbgo\/2025rbgo54"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo54","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo54"}}